NASDAQ · Analyst Forecast

Ernexa Therapeutics Inc. (ERNA) Stock Forecast & Price Target

$1.63 NASDAQ: ERNA Market Cap $2.76M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 17, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Ernexa Therapeutics Inc. (ERNA), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Ernexa Therapeutics Inc., analysts forecast revenue falling from $32.81M in 2025 to $0 in 2030; the average estimate for 2030 earnings per share is −$1.65; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$32.81M$32.81M$32.81M1
2026$75.35M$75.35M$75.35M1
2027$0$0$01
2028$0$0$01
2029$0$0$01
2030$0$0$01

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$4050.00−$4050.00−$4050.001
2026−$18.02−$18.02−$18.021
2027−$1.86−$1.86−$1.861
2028−$1.27−$1.27−$1.271
2029−$1.44−$1.44−$1.441
2030−$1.65−$1.65−$1.651

Ernexa Therapeutics Inc. (ERNA) forecast — frequently asked questions

What are analysts forecasting for Ernexa Therapeutics Inc.'s earnings?

The average analyst estimate for Ernexa Therapeutics Inc. (ERNA) earnings per share in 2030 is -1.65, with individual estimates between -1.65 and -1.65.

How much revenue is Ernexa Therapeutics Inc. expected to make?

Analysts forecast Ernexa Therapeutics Inc. (ERNA) revenue of $0 in 2030, based on 1 published estimates.

How many analysts cover ERNA?

1 analyst contribute estimates for Ernexa Therapeutics Inc. (ERNA). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.